Want to see DTIL full AI Analyst Report?
Total Valuation
Precision BioSciences has a market cap or net worth of $203.06M. The enterprise value is $62.77.
Market Cap$203.06M
Enterprise Value$62.77
Share Statistics
Precision BioSciences has 25,802,246 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding25,802,246
Owned by Insiders2.98%
Owned by Institutions0.17%
Financial Efficiency
Precision BioSciences’s return on equity (ROE) is -0.50 and return on invested capital (ROIC) is -35.47%.
Return on Equity (ROE)-0.50
Return on Assets (ROA)-0.30
Return on Invested Capital (ROIC)-35.47%
Return on Capital Employed (ROCE)-0.36
Revenue Per Employee519.15K
Profits Per Employee-692.79K
Employee Count66
Asset Turnover0.22
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Precision BioSciences is ―. Precision BioSciences’s PEG ratio is 0.00266.
PE Ratio―
PS Ratio1.56
PB Ratio0.58
Price to Fair Value0.58
Price to FCF-0.81
Price to Operating Cash Flow-3.09
PEG Ratio0.00266
Income Statement
In the last 12 months, Precision BioSciences had revenue of 34.26M and earned -45.72M in profits. Earnings per share was -3.56.
Revenue34.26M
Gross Profit34.26M
Operating Income-52.15M
Pretax Income-46.61M
Net Income-45.72M
EBITDA-42.43M
Earnings Per Share (EPS)-3.56
Cash Flow
In the last 12 months, operating cash flow was -58.73M and capital expenditures -54.00K, giving a free cash flow of -58.78M billion.
Operating Cash Flow-58.73M
Free Cash Flow-58.78M
Free Cash Flow per Share-2.28
Dividends & Yields
Precision BioSciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.61
52-Week Price Change51.44%
50-Day Moving Average7.42
200-Day Moving Average5.96
Relative Strength Index (RSI)43.22
Average Volume (3m)562.85K
Important Dates
Precision BioSciences upcoming earnings date is Aug 6, 2026, TBA (Confirmed).
Last Earnings DateMay 5, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Precision BioSciences as a current ratio of 13.32, with Debt / Equity ratio of 37.41%
Current Ratio13.32
Quick Ratio13.32
Debt to Market Cap0.42
Net Debt to EBITDA1.93
Interest Coverage Ratio-36.67
Taxes
In the past 12 months, Precision BioSciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Precision BioSciences EV to EBITDA ratio is 0.68, with an EV/FCF ratio of 0.43.
EV to Sales-0.84
EV to EBITDA0.68
EV to Free Cash Flow0.43
EV to Operating Cash Flow0.44
Balance Sheet
Precision BioSciences has $101.18M in cash and marketable securities with $28.47M in debt, giving a net cash position of $72.72M billion.
Cash & Marketable Securities$101.18M
Total Debt$28.47M
Net Cash$72.72M
Net Cash Per Share$2.82
Tangible Book Value Per Share$7.10
Margins
Gross margin is 100.00%, with operating margin of -152.19%, and net profit margin of -133.45%.
Gross Margin100.00%
Operating Margin-152.19%
Pretax Margin-136.03%
Net Profit Margin-133.45%
EBITDA Margin-123.84%
EBIT Margin-131.88%
Analyst Forecast
The average price target for Precision BioSciences is $33.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$33.00
Price Target Upside318.78% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast-11.87%
EPS Growth Forecast-86.91%